New heart valve implant offers hope for patients too sick for surgery

NCT ID NCT06581471

Recruiting now Disease control Sponsor: TRiCares Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new device called the TRiCares Topaz system to replace a leaky heart valve (tricuspid valve) without open-heart surgery. It will enroll 80 adults with severe leakage who are at high risk for traditional surgery. The goal is to see if the device is safe and can reduce the leak, helping patients feel better and walk farther.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder heart valve disorder tricuspid valve insufficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR DISEASES HEART VALVE DISEASE TRICUSPID VALVE REGURGITATION

Contacts and locations

Locations

AZ Delta
RECRUITING

Roeselare, 8800, Belgium
Algemeen Stedelijk Ziekenhuis
RECRUITING

Aalst, 9300, Belgium
Centre hospitalier universitaire CHU de Liège
NOT_YET_RECRUITING

Liège, Belgium
Cliniques Universitaires Saint-Luc UCL
RECRUITING

Brussels, Belgium
Ludwig Maximilian University Hospital
RECRUITING

Munich, 81377, Germany
UZ Brussel
RECRUITING

Brussels, 1090, Belgium
University Medical Center of the Johannes Gutenberg University Mainz
NOT_YET_RECRUITING

Mainz, 55131, Germany
ZNA Middelheim
RECRUITING

Antwerp, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.